Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve 1. Unaudited financial result for the quarter ended on June 30, 2025 along with the Limited Review Report of the Auditor pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015.2. Any other business with the permission of Chairman.